Please assess the completion status of the following clinical trial:

Trial Title: A Study of Infliximab (Remicade) in Patients With Ankylosing Spondylitis.

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Have had a diagnosis of definite Akylosing Spondylitis for at least 3 months prior to screening~* Have active disease with spinal pain~* receiving or intolerant to standard anti-inflammatory agents~Exclusion Criteria:~* Have Rheumatoid Arthritis, systemic lupus erythematosus, or other inflammatory rheumatic disease~* Have a documented history of fibromyalgia~* Have total ankylosis

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).